bromodeoxyuridine has been researched along with Carcinoma, Transitional Cell in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (29.63) | 18.7374 |
| 1990's | 15 (55.56) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Klinakis, A; Rampias, T | 1 |
| Chang, HL; Chen, HW; Kao, YH; Lin, KH; Su, JH; Wu, YC; Yeh, YT; Yuan, SS | 1 |
| Fukushima, S; Kaneko, M; Kinoshita, A; Kinoshita, H; Morimura, K; Nishikawa, T; Ogawa, M; Osugi, H; Salim, EI | 1 |
| Baba, S; Deguchi, N; Miyakawa, A; Murai, M; Tachibana, M; Tazaki, H | 1 |
| Miyakawa, A; Tachibana, M; Tazaki, H | 1 |
| Carroll, PR; Chew, K; Cohen, MB; Kerschmann, R; Mayall, BH; Waldman, FM | 2 |
| Baba, S; Deguchi, N; Miyakawa, A; Nakashima, J; Tachibana, M; Tazaki, H | 1 |
| Baba, S; Deguchi, N; Hata, M; Jitsukawa, S; Tachibana, M; Tazaki, H | 2 |
| Bair, R; Bernhart, P; Bigler, A; Limas, C; Reddy, P | 1 |
| Coptcoat, MJ; Joyce, AD; Popert, RJ; Thomas, DJ; Walmsley, BH | 1 |
| Baba, S; Miyakawa, A; Murai, M; Nakamura, K; Tachibana, M; Tazaki, H | 1 |
| Kawahara, K; Kitajima, I; Maruyama, I; Nakata, M; Yamakuchi, M | 1 |
| Deguchi, T; Hara, A; Katayama, M; Mori, H; Sugie, S; Tanaka, T; Vinh, PQ; Yamada, Y | 1 |
| Miyakawa, K; Morita, M; Sato, Y | 1 |
| Carroll, PR; Cohen, MB; Field, FG; Kerschmann, R; Mayall, BH; Waldman, FM | 1 |
| Coptcoat, M; Rew, DA; Thomas, DJ; Wilson, GD | 1 |
| Harada, M; Hattori, K; Koiso, K; Nemoto, R; Shimazui, T; Uchida, K | 2 |
| Hayashi, T; Hoshi, S; Kurosu, S; Mituno, S; Murakami, F; Nakazumi, H; Ohyama, C; Orikasa, S; Satoh, M; Yoshikawa, K | 1 |
| Hofstadter, F; Jenkins, WE; Knuchel, R; Masters, JR | 1 |
| Matsuyama, H; Sakatoku, J; Shimabukuro, T; Yamamoto, N; Yoshihiro, S | 1 |
| Harada, H; Mitsui, H; Sacho, T; Sakatoku, J; Shimabukuro, T; Yamamoto, M; Yamamoto, N | 1 |
| Harada, M; Hattori, K; Koiso, K; Miyanaga, N; Nemoto, R; Sasaki, A | 1 |
| Aoki, T; Fukushima, S; Inoue, T; Ito, N; Mera, Y; Tatematsu, M | 1 |
| Harada, M; Hattori, K; Koiso, K; Nemoto, R; Nishijima, Y; Saito, S; Shimazui, T; Uchida, K | 1 |
1 trial(s) available for bromodeoxyuridine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; DNA, Neoplasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ploidies; Predictive Value of Tests; Urinary Bladder Neoplasms | 1996 |
26 other study(ies) available for bromodeoxyuridine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Chromatids; Homologous Recombination; Humans; Sister Chromatid Exchange; Urinary Bladder Neoplasms | 2023 |
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Blotting, Western; Bromodeoxyuridine; Carcinoma, Transitional Cell; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique; Furans; G1 Phase; Humans; Lactones; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine.
Topics: Alleles; Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Esophageal Neoplasms; Genes, p53; Genetic Predisposition to Disease; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Nitrosamines; Organ Size; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Sequence Analysis, DNA; Time Factors; Urinary Bladder Neoplasms | 2003 |
A new scoring system based on the histological behavior and proliferative activity of tumor cells for grading the malignant potential of bladder cancers.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; DNA, Neoplasm; Follow-Up Studies; Humans; Neoplasm Staging; Ploidies; Regression Analysis; Retrospective Studies; Risk Factors; Survival Rate; Urinary Bladder Neoplasms | 1994 |
Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; DNA; Flow Cytometry; Humans; Neoplasm Invasiveness; Prognosis; Survival Rate; Urinary Bladder Neoplasms | 1995 |
5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
Topics: Aged; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Female; Humans; Male; Neoplasm Staging; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Urinary Bladder Neoplasms | 1993 |
Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Humans; Ki-67 Antigen; Mitosis; Neoplasm Proteins; Nuclear Proteins; Nucleolus Organizer Region; Proliferating Cell Nuclear Antigen; Urinary Bladder Neoplasms | 1993 |
Flow cytometric bromodeoxyuridine/deoxyribonucleic acid bivariate analysis for predicting tumor invasiveness of upper tract urothelial cancer.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney; Kidney Neoplasms; Neoplasm Invasiveness; Ploidies; Proportional Hazards Models; Survival Analysis; Survival Rate; Ureter; Ureteral Neoplasms | 1994 |
Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Topics: Actuarial Analysis; Bromodeoxyuridine; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Follow-Up Studies; Humans; Ploidies; Prognosis; Proportional Hazards Models; Survival Analysis; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1993 |
Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.
Topics: Antigens, Neoplasm; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Count; Cell Division; Humans; Ki-67 Antigen; Middle Aged; Mitotic Index; Neoplasm Proteins; Nuclear Proteins; Nucleolus Organizer Region; Prognosis; Urinary Bladder Neoplasms | 1993 |
Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder--an index of recurrence?
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Prognosis; Urinary Bladder Neoplasms | 1993 |
New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines.
Topics: Anti-Infective Agents; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; DNA, Neoplasm; Humans; Levofloxacin; Ofloxacin; Telomerase; Tumor Cells, Cultured | 1997 |
Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cell Cycle; Cyclin D1; Male; Mice; Mice, Inbred ICR; Papilloma; Precancerous Conditions; Silymarin; Urinary Bladder Neoplasms | 2002 |
Combined surgery, radiotherapy and regional chemotherapy in carcinoma of the maxillary sinus.
Topics: Bromodeoxyuridine; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Fluorouracil; Humans; Injections, Intra-Arterial; Maxillary Sinus; Methods; Paranasal Sinus Neoplasms | 1978 |
Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
Topics: Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Centromere; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 9; Female; Humans; Interphase; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Urinary Bladder Neoplasms | 1991 |
Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney Neoplasms; Kinetics; Male; Mitosis; Penile Neoplasms; Prostatic Neoplasms; S Phase; Urinary Bladder Neoplasms | 1991 |
Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Immunoenzyme Techniques; Urinary Bladder; Urinary Bladder Neoplasms | 1991 |
Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.
Topics: Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Humans; Male; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1990 |
[S-phase cells of human bladder tumors by in vivo bromodeoxyuridine labeling].
Topics: Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Interphase; Male; Middle Aged; Urinary Bladder Neoplasms | 1990 |
Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
Topics: Administration, Topical; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Survival; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1989 |
[Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis--study with urogenital tumors].
Topics: Aged; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; Child; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Tumor Cells, Cultured; Urogenital Neoplasms | 1989 |
[Cell kinetic study of urogenital tumors utilizing in vitro BrdU-labelling method and anti-BrdU monoclonal antibody].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Lymphoma; Male; Middle Aged; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1989 |
Estimations of the S phase fraction in situ in transitional cell carcinoma of the renal pelvis and ureter with bromodeoxyuridine labelling.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Humans; Interphase; Kidney Neoplasms; Kidney Pelvis; Ureteral Neoplasms | 1989 |
Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
Topics: Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Division; Epithelial Cells; Epithelium; Hyperplasia; Male; Nitrosamines; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
[Cell cycle kinetics of human bladder tumor in situ measured by bromodeoxyuridine (BrdU)].
Topics: Adult; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; Female; Humans; Male; Middle Aged; Urinary Bladder Neoplasms | 1988 |
S phase fraction of human bladder tumor measured in situ with bromodeoxyuridine labeling.
Topics: Adult; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Female; Humans; Immunoenzyme Techniques; Interphase; Male; Middle Aged; Urinary Bladder Neoplasms | 1988 |